Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults

NCT01162590 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL: Rotarix ™
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline